MEDICINA PREVENTIVA Y SALUD PÚBLICA
Departamento
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (11)
2023
2020
-
Factors associated with the number of drugs in darunavir/cobicistat regimens
Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 208-214
2019
-
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Scientific Reports, Vol. 9, Núm. 1
2018
-
Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study
Scientific Reports, Vol. 8, Núm. 1
2017
-
Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013
Helicobacter, Vol. 22, Núm. 5
2016
-
Perinatal and childhood factors and risk of prostate cancer in adulthood: MCC-Spain case-control study
Cancer Epidemiology, Vol. 43, pp. 49-55
2015
-
Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus
Clinical Infectious Diseases, Vol. 60, Núm. 6, pp. 950-958
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2014
-
Effects of sustained viral response in patients with HIV and chronic hepatitis C and nonadvanced liver fibrosis
Journal of Acquired Immune Deficiency Syndromes, Vol. 66, Núm. 3, pp. 280-287
2013
-
Atrial fibrillation and stroke risk after coronary artery bypass grafting surgery
Journal of Atrial Fibrillation, Vol. 6, Núm. 3, pp. 23-28
2011
-
Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus
Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 12, pp. 2843-2849